“…16 In a retrospective study of 35 patients with chronic kidney disease, out of 229 who had an ICD implanted for primary prevention, Cuculich et al registered a one-year survival of 61.8% in patients with a serum creatinine of >177 µmol/l or on chronic dialysis, compared with 96.3% in controls. 17 This lack of benefit in the more diseased population was also apparent in the SCDHeFT trial: whereas in NYHA class II patients there was a 46% reduction in risk of death, patients in NYHA class III had no advantage with an ICD compared with placebo.…”